Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H35N9O8S |
Molecular Weight | 597.645 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O
InChI
InChIKey=MMHDBUJXLOFTLC-WOYTXXSLSA-N
InChI=1S/C23H35N9O8S/c1-11(34)32-4-2-3-17(32)23(40)29-14(5-12-7-26-10-27-12)20(37)30-15(8-33)21(38)31-16(9-41)22(39)28-13(19(25)36)6-18(24)35/h7,10,13-17,33,41H,2-6,8-9H2,1H3,(H2,24,35)(H2,25,36)(H,26,27)(H,28,39)(H,29,40)(H,30,37)(H,31,38)/t13-,14-,15-,16-,17-/m0/s1
Molecular Formula | C23H35N9O8S |
Molecular Weight | 597.645 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:29:17 UTC 2023
by
admin
on
Fri Dec 15 16:29:17 UTC 2023
|
Record UNII |
XW0H5LE42K
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C2050
Created by
admin on Fri Dec 15 16:29:17 UTC 2023 , Edited by admin on Fri Dec 15 16:29:17 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID60180877
Created by
admin on Fri Dec 15 16:29:17 UTC 2023 , Edited by admin on Fri Dec 15 16:29:17 UTC 2023
|
PRIMARY | |||
|
C52185
Created by
admin on Fri Dec 15 16:29:17 UTC 2023 , Edited by admin on Fri Dec 15 16:29:17 UTC 2023
|
PRIMARY | NCIT | ||
|
9960285
Created by
admin on Fri Dec 15 16:29:17 UTC 2023 , Edited by admin on Fri Dec 15 16:29:17 UTC 2023
|
PRIMARY | |||
|
DB05491
Created by
admin on Fri Dec 15 16:29:17 UTC 2023 , Edited by admin on Fri Dec 15 16:29:17 UTC 2023
|
PRIMARY | |||
|
262438-43-7
Created by
admin on Fri Dec 15 16:29:17 UTC 2023 , Edited by admin on Fri Dec 15 16:29:17 UTC 2023
|
PRIMARY | |||
|
XW0H5LE42K
Created by
admin on Fri Dec 15 16:29:17 UTC 2023 , Edited by admin on Fri Dec 15 16:29:17 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
A small peptide antagonist of integrin alpha5beta1 with potential antineoplastic activity. ATN-161 selectively binds to and blocks the receptor for integrin alpha5beta1, thereby preventing integrin alpha.5beta1 binding.
|
||
|
ACTIVE MOIETY |
ATN-161 was well tolerated at all dose levels. Approximately, 1/3 of the patients in the study manifested prolonged stable disease. These findings suggest that ATN-161 should be investigated further as an antiangiogenic and antimetastatic cancer agent alone or with chemotherapy.
|